Pharma formulation translation remained a centerpiece of platform innovation. The Journal of Pharmaceutical Investigation announced a January 2027 special issue focused on translational advances in particle engineering and formulation science, with a submissions deadline of June 30, 2026. On the enabling technology side, MIT chemical engineers reported an automated, self-correcting lipid nanoparticle platform that rapidly produces precisely controlled LNP sizes and shapes. The design targets faster RNA therapy or vaccine formulation iterations and could reduce bottlenecks from manual development cycles. Both updates point to the same practical bottleneck: moving from lab-scale discovery to manufacturable, repeatable platforms at higher speed without sacrificing control.